Precipio Enters Into an At-The -Market (ATM) Financing Arrangement
April 05, 2021 09:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., April 05, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces a new “At-The-Market” (ATM) financing arrangement that improves its...
Precipio Announces 95% Annual Growth YoY and 180% Quarterly Growth YoY
March 30, 2021 09:00 ET
|
Precipio, Inc.
FY-2020FY-2019Increase (%)Increase ($)Revenues$6.1M$3.1M↑ 95%↑ $3.0MGross profit$1.2M$0.3M↑ 425%↑ $0.9M Q4-2020Q3-2020 Increase (%)Increase ($)Revenues$1.9M$1.6M↑ 19%↑ $0.3MGross...
Precipio Announces Q4-2020 and year-end Shareholder Update Call
March 18, 2021 16:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., March 18, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4-2020 and year end corporate update call on Wednesday,...
Mr. Ron Andrews joins Precipio’s Board of Directors
March 03, 2021 13:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., March 03, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that Mr. Ron Andrews has joined the company’s Board of Directors. As...
Mr. Richard Sandberg is appointed Chairman of Precipio’s Board of Directors
March 03, 2021 11:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., March 03, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces the appointment of Mr. Richard Sandberg as Chairman of the Board of...
Precipio Launches COVID-19 Antibody Testing at Point-of-Care
January 28, 2021 09:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that following receipt of an Emergency Use Authorization from the FDA...
Precipio Signs HemeScreen™ Deals with Two Leading Oncology Groups
January 20, 2021 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has signed agreements with two of the largest oncology practices in the US,...
Precipio Signs Sales & Marketing Agreement for HemeScreen™ with Major Oncology Distributor
December 10, 2020 10:15 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has entered into an agreement with a major US-based oncology distributor to...
Precipio Announces Q3-2020 Shareholder Update Call
November 11, 2020 09:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2020 corporate update call on Thursday, November 19th...
Precipio & ADS Biotec Launch Seven Beta sites for IV-Cell™
October 06, 2020 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), along with its partner ADS Biotec announce the launch of the beta phase...